Data / Form D filings / KINETA, INC./DE
KINETA, INC./DE: Form D filings
KINETA, INC./DE, a biotechnology company in Seattle, WA, filed 8 Form D notices with the SEC between 2011 and 2023. The latest, on October 20, 2023, reports an offering of $2.9 million with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 219 TERRY AVE. N., SUITE 300, Seattle, WA, 98109
- Phone
- (206) 378-0400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1445283
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20, 2023 | New notice | $2,893,176 | $0 | $2,893,176 | 1 | Oct 3, 2023 | sec.gov |
| Dec 29, 2022 | New notice | $30,000,000 | $7,500,000 | $22,500,000 | 17 | Dec 16, 2022 | sec.gov |
| Jan 6, 2021 | New notice | $33,599,895 | $33,599,895 | 16 | Dec 22, 2020 | sec.gov | |
| Sep 15, 2015 | New notice | $27,999,992 | $21,999,992 | $6,000,000 | 9 | Sep 1, 2015 | sec.gov |
| Sep 15, 2015 | Amendment | $15,000,000 | $15,000,000 | 8 | Jul 31, 2014 | sec.gov | |
| Oct 7, 2014 | Amendment | $10,000,000 | $5,000,000 | $5,000,000 | 7 | Jul 31, 2014 | sec.gov |
| Aug 14, 2014 | New notice | $10,000,000 | $3,012,271 | $6,987,729 | 5 | Jul 31, 2014 | sec.gov |
| Jun 2, 2011 | Amendment | $81,760,000 | $70,623,000 | $11,137,000 | 7 | Aug 15, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shawn P. Iadonato | Executive Officer, Director | |
| Pauline A. Kenny | Executive Officer | |
| Craig W. Philips | Executive Officer | |
| Richard R. Peters | Director | |
| Marion R. Foote | Director | |
| Thierry A. Guillaudeux | Executive Officer | |
| Raymond R. Bartoszek | Director | |
| Keith A. Baker | Executive Officer | |
| Kimberlee C. Drapkin | Director | |
| Scott J. Dylla | Director | |
| David R. Arkowitz | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Oct 16, 2023 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KINETA, INC./DE reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.